Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Files

Singh_NInt_J_Gynecol_Pathol_2019.pdf (539.53 KB)

Document type

Article

Version

Published version

Publication date

2019-01-01

Publication license

cc by (c) International Society of Gynecological Pathologists, 2019
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/128329

Pathologic Prognostic Factors in Endometrial Carcinoma (Other Than Tumor Type and Grade)

Journal Title

Authors

Director/Tutor

Journal ISSN

Volume Title

Related resource

http://dx.doi.org/ 10.1097/PGP.0000000000000524

Abstract

Although endometrial carcinoma (EC) is generally considered to have a good prognosis, over 20% of women with EC die of their disease, with a projected increase in both incidence and mortality over the next few decades. The aim of accurate prognostication is to ensure that patients receive optimal treatment and are neither overtreated nor undertreated, thereby improving patient outcomes overall. Patients with EC can be categorized into prognostic risk groups based on clinicopathologic findings. Other than tumor type and grade, groupings and recommended management algorithms may take into account age, body mass index, stage, and presence of lymphovascular space invasion. The molecular classification of EC that has emerged from the Cancer Genome Atlas (TCGA) study provides additional, potentially superior, prognostic information to traditional histologic typing and grading. This classifier does not, however, replace clinicopathologic risk assessment based on parameters other than histotype and grade. It is envisaged that molecular and clinicopathologic prognostic grouping systems will work better together than either alone. Thus, while tumor typing and grading may be superseded by a classification based on underlying genomic abnormalities, accurate assessment of other pathologic parameters will continue to be key to patient management. These include those factors related to staging, such as depth of myometrial invasion, cervical, vaginal, serosal surface, adnexal and parametrial invasion, and those independent of stage such as lymphovascular space invasion. Other prognostic parameters will also be discussed. These recommendations were developed from the International Society of Gynecological Pathologists Endometrial Carcinoma project.

Subject

Càncer d'endometri, Pronòstic mèdic

Subject (English)

Endometrial cancer, Prognosis

Citation

Collections

Articles publicats en revistes (ISGlobal)

Citation

SINGH, Naveena, et al. Pathologic Prognostic Factors in Endometrial Carcinoma (Other
                Than Tumor Type and Grade). International Journal of Gynecological Pathology. 2019. Vol. 38 Suppl 1, num. :S93–S113. ISSN 0277-1691. [consulted: 10 of August of 2026]. Available at: https://hdl.handle.net/2445/128329

Export metadata

JSON - METS

Share record